clinical trials

Pharmacist Intervention Improves Diabetes Drug TrialsInterventions by pharmacists can help improve the results of diabetes clinical trials.
Payers to pharma: Here’s what we’re missing in hep C drugsA Precision for Value survey highlights what can be done in order to encourage payers to ease coverage policies for these drugs in the next wave of HCV treatment.
How precision medicine is improving patient lives: Real examplesAn expert at the Precision Medicine World Conference shared cancer patient perspectives on the importance of immuno-oncology and breakthrough targeted therapies and how they have extended their lives.
HHS makes clinical trials more transparentHHS finalized rules encourage healthcare improvement and public benefit by increasing transparency and accountability across the industry.
IRIS Registry may do more than improve patient outcomesThe IRIS Registry can improve patient outcomes by giving physicians access to information that could identify potential areas of quality improvement based on their patient population.
IPF drug to be tested with add-on therapyBoehringer Ingelheim recently began a clinical trial to assess the safety and tolerability of adding on pirfenidone to Ofev (nintedanib) for idiopathic pulmonary fibrosis patients.
New bill aims to speed FDA approval of drugs and medical devicesA new bill looks to decrease the time for the development and release of new drugs and medical devices by modernizing clinical trials and removing barriers to collaboration and innovation, according to legislators.
How to start a clinical trial programConducting clinical trials offers the opportunity to collaborate in the development of new drugs and devices. This is one expert's advice for setting up your own clinical trials program.
Pediatric trials for AD systemic treatmentsAt a recent meeting, the Food and Drug Administration Dermatologic and Ophthalmic Drugs Advisory Committee supported early clinical development of systemic products for pediatric patients with atopic dermatitis that has been inadequately responsive to topical therapies.
Statins cost-effective in elderly patients: StudyStatins could be a cost-effective tool for preventing heart attacks and other cardiovascular incidents in adults over aged 75 years, but the benefits would need to be weighed against potential side effects, a study in the Annals of Internal Medicine.